Insights

Investors eagerly back Japara ahead of its float, while National Australia Bank is reportedly mulling the sale of MLC's life insurance business.

The government's B20 advisory forum has made corruption a core issue.

An electoral thrashing and the token replacement of his Prime Minister won't stop François Hollande from determining France's direction, but his track record so far offers little cause for optimism.

Westfield talks up Australasian spin-off Scentre to disgruntled investors.

Nursing home giant expected to lodge its prospectus by early next week.

BHP Billiton has sold its West Musgrave nickel-copper project in WA for a song.

BP is in talks to buy more petrol stations despite oil refinery closure.

John Neal pledges to vigorously defend company against class actions.

The Competition Tribunal will have to consider several arguments from AGL as the energy giant tries to prove its $1.5 billion acqusition of Macquarie Generation would be in the public interest.

A further surge in house prices and bank profits, without improved economic trends, would be a danger signal.

Our market has flatlined for no solid reason. Is it time to sell out?

Blue-chips running consistent dividend reinvestment plans beat the wider market by 20%.

This week we look at Nufarm, TPG Telecom, Premier Investments, Sigma Pharmaceuticals and Qube Holdings.

Local market edges into the black, boosted by gains in the major miners.

The retail chain has been placed in the hands of administrators, although its stores will remain open and trading.

That Andrew Bolt had expected more support from Jewish leaders for his free speech campaign suggests uncomfortable things in the context of the debate over section 18C.